Variant report
Variant | esv3421521 |
---|---|
Chromosome Location | chr9:2692548-2692976 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532639971 | chr9:2692552-2692553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs184334265 | chr9:2692572-2692573 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565323400 | chr9:2692577-2692578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2375981 | chr9:2692583-2692584 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs547979879 | chr9:2692588-2692589 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs2375980 | chr9:2692622-2692623 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs368700507 | chr9:2692696-2692697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs202018252 | chr9:2692704-2692705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs4520216 | chr9:2692725-2692726 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs557070084 | chr9:2692747-2692748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541432426 | chr9:2692762-2692763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188984478 | chr9:2692771-2692772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11787847 | chr9:2692773-2692774 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs138813455 | chr9:2692793-2692794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572449676 | chr9:2692812-2692813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181705951 | chr9:2692913-2692914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs186147322 | chr9:2692936-2692937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574829894 | chr9:2692948-2692949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533446374 | chr9:2692958-2692959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1987496 | chr9:2692966-2692967 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 16715143 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 21373258 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Schizophrenia | 20967226 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:2687200-2693200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr9:2688600-2702400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr9:2689800-2700200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr9:2690000-2692600 | Enhancers | HUVEC | blood vessel |
5 | chr9:2690000-2702600 | Weak transcription | Primary T cells from cord blood | blood |
6 | chr9:2690600-2718000 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr9:2690800-2700600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr9:2691200-2710600 | Weak transcription | Left Ventricle | heart |
9 | chr9:2691400-2692600 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
10 | chr9:2692000-2709600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr9:2692200-2693200 | Weak transcription | Fetal Heart | heart |